Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 622  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission


    Article Cited by others

LETTER

Ipilimumab: Melanoma and beyond

Patel Vishal, Gandhi Hardik, Upaganlawar Aman

Year : 2011| Volume: 3| Issue : 4 | Page no: 546-546

   This article has been cited by
 
1 Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response
Elisa C. Toffoli, Abdolkarim Sheikhi, Yannick D. Höppner, Pita de Kok, Mahsa Yazdanpanah-Samani, Jan Spanholtz, Henk M. W. Verheul, Hans J. van der Vliet, Tanja D. de Gruijl
Cancers. 2021; 13(4): 711
[Pubmed]  [Google Scholar] [DOI]
2 Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells
Margherita Passariello, Simona Camorani, Cinzia Vetrei, Stefania Ricci, Laura Cerchia, Claudia De Lorenzo
Cancers. 2020; 12(2): 331
[Pubmed]  [Google Scholar] [DOI]
3 Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells
Margherita Passariello, Cinzia Vetrei, Emanuele Sasso, Guendalina Froechlich, Chiara Gentile, Anna Morena D'Alise, Nicola Zambrano, Elisa Scarselli, Alfredo Nicosia, Claudia De Lorenzo
Cancers. 2020; 12(8): 2204
[Pubmed]  [Google Scholar] [DOI]

 

Read this article